News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Intern sees cancer research from both sides
A young woman with a rare perspective on pediatric cancer is now considering where science can take her after completing a successful internship at Hudson Institute.… Read more
-
Tiny RNA fragments unlock massive autoimmune treatment potential
RNA-based medicine is about to take a huge leap forward thanks to the discovery of extremely short RNA fragments with important anti-inflammatory properties.… Read more
-
Safer Baby Bundle saves lives – and it’s only the beginning
Fewer stillbirths and reduced perinatal mortality: they are the key findings of the first analysis of the Safer Baby Bundle, Australia’s national stillbirth prevention program.… Read more
-
The crucial role of the chest wall in baby’s first breaths
A baby’s first breaths involve more than just getting air into the lungs, and for the first time research has identified the important role of the chest wall in this process.… Read more
-
2025 NHMRC Ideas Grant success
Hudson Institute research has been recognised in this year’s National Health and Medical Research Council (NHMRC) Ideas Grants, with seven projects receiving funding.… Read more
-
ROC Inc funding turns action into hope for rare ovarian cancers
A Hudson Institute research project aiming to better understand and treat rare forms of ovarian cancer has received a big funding boost.… Read more
-
Childhood cancer catalog opens door to paediatric immunotherapy
The Children’s Cancer Model Atlas, or CCMA, located at Hudson Institute, is the world’s largest collection of paediatric cancer cell lines, giving researchers the chance to test and analyse potential treatments using cutting-edge AI techniques.… Read more
-
Too much of a good thing: 100% oxygen damages newborn lungs
The latest research from Hudson Institute of Medical Research, Monash Children’s Hospital and the Department of Pediatrics at Monash University has shown that use of 100% oxygen at birth causes lung injury regardless of how the umbilical cord is managed, so high-oxygen resuscitation should be avoided.… Read more
-
Pankind backs Hudson Institute immunotherapy research for pancreatic cancer
A/Prof Pouya Faridi and his team has received funding from Pankind for his crucial work on immune therapies for pancreatic cancer research. … Read more
-
New Primary Aldosteronism treatment target identified
Identifying a disease is one thing, establishing the best treatment option is another entirely, and in the case of Primary Aldosteronism (PA) the team at Hudson Institute of Medical Research is well on the way to both.… Read more